Ascentage Pharma Schedules Crucial Financial Review
Company Announcements

Ascentage Pharma Schedules Crucial Financial Review

Ascentage Pharma Group International (HK:6855) has released an update.

Ascentage Pharma Group International is set to hold a board meeting on August 22, 2024, to review and potentially approve their unaudited financial results for the first half of the year. The meeting’s outcomes are eagerly anticipated by shareholders and market watchers, as they will provide insights into the company’s recent performance and future prospects.

For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App